
Becton Dickinson ownership: holders and insider trading
$218.03+1.08%Close 13 Nov 2026 · Market value $59.20B
As filed, its directors and officers own 0.4% of the shares (proxy statement, 1 Dec 2025); 1,434 institutional managers reported holding 99.6% at 30 Jun 2026. Over the last twelve months, insiders sold $2.73M of shares on the open market, $2.12M of it under 10b5-1 plans set in advance, and bought none.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| Vanguard | Institution | 35.9M | 13.19%* | Form 13F | 30 Jun 2026 |
|---|
| First Eagle Investment Management, LLC | Institution | 27.6M | 10.14%* | Form 13F | 30 Jun 2026 |
|---|
| BlackRock | Institution | 24.6M | 9.03%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard Capital Management | Holder | 21.4M | 7.51% | Schedule 13G | 31 Mar 2026 |
|---|
| Vanguard Portfolio Management | Holder | 15.4M | 5.4% | Schedule 13G | 31 Mar 2026 |
|---|
| State Street | Institution | 15.0M | 5.51%* | Form 13F | 30 Jun 2026 |
|---|
| Invesco | Institution | 8.9M | 3.27%* | Form 13F | 30 Jun 2026 |
|---|
| Massachusetts Financial Services Co | Institution | 8.7M | 3.18%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 8.1M | 2.99%* | Form 13F | 30 Jun 2026 |
|---|
| T. Rowe Price | Institution | 7.6M | 2.80%* | Form 13F | 30 Jun 2026 |
|---|
| Franklin Templeton | Institution | 7.0M | 2.57%* | Form 13F | 30 Jun 2026 |
|---|
| Wellington Management | Institution | 6.4M | 2.33%* | Form 13F | 30 Jun 2026 |
|---|
| Greenhaven Associates Inc | Institution | 5.7M | 2.09%* | Form 13F | 30 Jun 2026 |
|---|
| Norges Bank | Institution | 4.2M | 1.53%* | Form 13F | 30 Jun 2026 |
|---|
| American Century Companies Inc | Institution | 3.7M | 1.35%* | Form 13F | 30 Jun 2026 |
|---|
| Charles Schwab | Institution | 3.4M | 1.25%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 3.3M | 1.22%* | Form 13F | 30 Jun 2026 |
|---|
| Clearbridge Investments, LLC | Institution | 3.2M | 1.19%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 3.1M | 1.15%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 3.0M | 1.10%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Feld Michael · EVP, Chief Revenue Officer | 28 Sep 2026 | Open-market sale (10b5-1 plan) | −76 | $183.70 | $13.96K |
|---|
| Roque Vitor · EVP & Chief Financial Officer | 2 Sep 2026 | Shares withheld for tax | −190 | — | — |
|---|
| Feld Michael · EVP, Chief Revenue Officer | 26 Aug 2026 | Open-market sale (10b5-1 plan) | −165 | $188.49 | $31.10K |
|---|
| Feld Michael · EVP, Chief Revenue Officer | 20 Aug 2026 | Shares withheld for tax | −1.0K | — | — |
|---|
| Polen Thomas E Jr · Chairman, CEO and President · Director | 13 Aug 2026 | Open-market sale (10b5-1 plan) | −4.2K | $185.00 | $768.1K |
|---|
| Polen Thomas E Jr · Chairman, CEO and President · Director | 13 Aug 2026 | Option exercise | +43.3K | $167.25 | $7.24M |
|---|
| Goette Roland · EVP and President, EMEA | 11 Aug 2026 | Open-market sale | −2.4K | $180.84 | $440.9K |
|---|
| Feld Michael · EVP, Chief Revenue Officer | 27 Jul 2026 | Open-market sale (10b5-1 plan) | −75 | $157.13 | $11.78K |
|---|
| Muhsin Bilal · EVP & President Connected Care | 2 Jul 2026 | Shares withheld for tax | −1.9K | — | — |
|---|
| Muhsin Bilal · EVP & President Connected Care | 1 Jul 2026 | Grant or award | +14.3K | — | — |
|---|
| Feld Michael · EVP, Chief Revenue Officer | 26 Jun 2026 | Open-market sale (10b5-1 plan) | −75 | $152.80 | $11.46K |
|---|
| Garrison Michael David · EVP & Pres Med.Essntl&BioPharm | 24 Jun 2026 | Open-market sale (10b5-1 plan) | −1.1K | $145.66 | $160.2K |
|---|
| Garrison Michael David · EVP & Pres Med.Essntl&BioPharm | 10 Jun 2026 | Open-market sale (10b5-1 plan) | −1.1K | $151.48 | $166.6K |
|---|
| Polen Thomas E Jr · Chairman, CEO and President · Director | 1 Jun 2026 | Option exercise | +20.2K | $126.16 | $2.55M |
|---|
| Polen Thomas E Jr · Chairman, CEO and President · Director | 1 Jun 2026 | Open-market sale (10b5-1 plan) | −2.8K | $146.35 | $404.5K |
|---|
| Menziuso Peter · EVP and President, BDI | 1 Jun 2026 | Grant or award | +14.3K | — | — |
|---|
| Feld Michael · EVP, Chief Revenue Officer | 26 May 2026 | Open-market sale (10b5-1 plan) | −75 | $147.35 | $11.05K |
|---|
| Roque Vitor · EVP & Chief Financial Officer | 7 May 2026 | Grant or award | +1.7K | — | — |
|---|
| Feld Michael · EVP, Chief Revenue Officer | 27 Apr 2026 | Open-market sale (10b5-1 plan) | −74 | $151.94 | $11.24K |
|---|
| Neal Shana Carol · EVP and Chief People Officer | 6 Apr 2026 | Shares withheld for tax | −1.1K | — | — |
|---|
| Feld Michael · EVP, Chief Revenue Officer | 26 Mar 2026 | Open-market sale (10b5-1 plan) | −75 | $156.83 | $11.76K |
|---|
| Minnix Lanesha · EVP and General Counsel | 16 Mar 2026 | Grant or award | +7.5K | — | — |
|---|
| Roque Vitor · Interim CFO | 2 Mar 2026 | Grant or award | +931 | — | — |
|---|
| Spikner Pamela L. · SVP Controller & CAO | 2 Mar 2026 | Grant or award | +931 | — | — |
|---|
| Feld Michael · EVP, Chief Revenue Officer | 26 Feb 2026 | Open-market sale (10b5-1 plan) | −75 | $181.84 | $13.64K |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
BDX in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.